Drugs / Triamcinolone Hexacetonide (TH)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04231318 Comparator | Sep 2020 → May 2022 | osteoarthritis, knee | Anika Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triamcinolone Hexacetonide (TH) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04231318 ↗ |
| Route | Other | “Single intra-articular injection of TH into the knee.” NCT04231318 ↗ |